The relationship between heart rate variability and time-course of carcinoembryonic antigen in colorectal cancer

Autonomic Neuroscience: Basic and Clinical

Volumn 166, Issue 1-2, 2012, Pages 96-99

  Mouton, Charlotte ^a   Ronson, Alain ^b   Razavi, Darius ^b   Delhaye, François ^b   Kupper, Nina ^c   Paesmans, Marianne ^b   Moreau, Michel ^b   Nogaret, Jean Marie ^b   Hendlisz, Alain ^b   Gidron, Yori ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b JULES BORDET INSTITUTE   (Belgium)

^c TILBURG UNIVERSITY   (Netherlands)

Author keywords

Carcinoembryonic antigen (CEA); Colon cancer; Heart rate variability (HRV); Prognostic factor; Vagal nerve

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; HEART DISEASE; HEART RATE VARIABILITY; HUMAN; INFLAMMATORY DISEASE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VAGUS NERVE;

AGED; ARRHYTHMIAS, CARDIAC; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; PROSPECTIVE STUDIES; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; VAGUS NERVE DISEASES;

EID: 84855961626     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2011.10.002     Document Type: Article

References (33)

1. Atkins M.B., Redman B., Mier J., Gollob J., Weber J., Sosman J., MacPherson B.L., Plasse T. A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanoma. Clin. Cancer Res. 2001, 7:486-492.
2. Bernik T.R., Friedman S.G., Ochani M., DiRaimo R., Ulloa L., Yang H., Sudan S., Czura C.J., Ivanova S.M., Tracey K.J. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J. Exp. Med. 2002, 195:781-788.
3. Chiang J.K., Koo M., Kuo T.B., Fu C.H. Association between cardiovascular autonomic functions and time to death in patients with terminal hepatocellular carcinoma. J. Pain Symptom Manage. 2010, 39(4):673-679.
4. D'Souza M.J., Oettinger C.W., Milton G.V., Tracey K.J. Prevention of lethality and suppression of proinflammatory cytokines in experimental septic shock by microencapsulated CNI-1493. J. Interferon Cytokine Res. 1999, 19:1125-1133.
5. Dekker J.M., Schouten E.G., Klootwojk P., Pool J., Swenne C.A., Kromhout D. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. Am. J. Epidemiol. 1997, 145(10):899-908.
6. Ekbom A., Lundegardh G., McLaughlin J.K., Nyren O. Relation of vagotomy to subsequent risk of lung cancer: population based cohort study. BMJ 1998, 316:518-519.
7. Entschladen F., Drell T.L., Lang K., Joseph J., Zaenker K.S. Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. Lancet Oncol. 2004, 5(4):254-258.
8. Erin N., Akdas Barkan G., Harms J.F., Clawson G.A. Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters substance P level. Regul. Pept. 2008, 151(1-3):35-42.
9. Fadul N., Strasser F., Palmer L.J., Yusuf S.W., Guo Y., Li Z., Allo J., Bruera E. The association between autonomic dysfunction and survival in male patients with advanced cancer: a preliminary report. J. Pain Symptom Manage. 2010, 39(2):283-290.
10. Faux S.P., Tai T., Thorne D., Xu Y., Breheny D., Gaca M. The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke. Biomarkers 2009, 14(Suppl. 1):90-96.
11. Forslund A., Engarås B., Lönnroth C., Lundholm K. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma. Int. J. Oncol. 2002, 20(5):1013-1018.
12. Gidron Y., Perry H., Glennie M. Does the vagus nerve inform the brain about preclinical tumours and modulate them?. Lancet Oncol. 2005, 6:245-248.
13. Hamilton R.M., McKechnie P.S., Macfarlane P.W. Can cardiac vagal tone be estimated from the 10-second ECG?. Int. J. Cardiol. 2004, 95(1):109-115.
14. Hoffmann J., Grimm W., Menz V., Wied M., Sprenger A., Arnold R., Maisch B. Prognostic value of heart rate variability analysis in patients with carcinoid syndrome. Digestion 2001, 63(1):35-42.
15. Iwanicki-Caron I., Di Fiore F., Roque I., Astruc E., Stetiu M., Duclos A., Tougeron D., Saillard S., Thureau S., Benichou J., Paillot B., Basuyau J.P., Michel P. Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancer. J. Clin. Oncol. 2008, 26(22):3681-3686.
16. Karavidas M.K., Lehrer P.M., Vaschillo E., Vaschillo B., Marin H., Buyske S., Malinovsky I., Radvanski D., Hassett A. Preliminary results of an open label study of heart rate variability biofeedback for the treatment of major depression. Appl. Psychophysiol. Biofeedback 2007, 32(1):19-30.
17. Kim do H., Kim J.A., Choi Y.S., Kim S.H., Lee J.Y., Kim Y.E. Heart rate variability and length of survival in hospice cancer patients. J. Korean Med. Sci. 2010, 25(8):1140-1145.
18. Kuo T.B., Lai C.J., Huang Y.T., Yang C.C. Regression analysis between heart rate variability and baroreflex-related vagus nerve activity in rats. J. Cardiovasc. Electrophysiol. 2005, 16(8):864-869.
19. Labianca R., Nordlinger B., Beretta G.D., Brouquet A., Cervantes A., ESMO Guidelines Working Group Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up. Ann. Oncol. 2010, 21(Suppl. 5):70-77.
20. Lehrer P.M., Vaschillo E., Vaschillo B., Lu S.E., Scardella A., Siddique M., Habib R.H. Biofeedback treatment for asthma. Chest 2004, 126(2):352-361.
21. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
22. Mravec B., Gidron Y., Kukanova B., Bizik J., Kiss A., Hulin I. Neural-endocrine-immune complex in the central modulation of tumorigenesis: facts, assumptions, and hypotheses. J. Neuroimmunol. 2006, 180(1-2):104-116.
23. Murphy J.V., Patil A. Stimulation of the nervous system for the management of seizures: current and future developments. CNS Drugs 2003, 17:101-115.
24. Ondicova K., Mravec B. Role of nervous system in cancer aetiopathogenesis. Lancet Oncol. 2010, 11:596-601.
25. Park Y.J., Park K.J., Park J.G., Lee K.U., Choe K.J., Kim J.P. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J. Surg. 1999, 23(7):721-726.
26. Pavithran P., Nandeesha H., Sathiyapriya V., Bobby Z., Madanmohan T. Short-term heart variability and oxidative stress in newly diagnosed essential hypertension. Clin. Exp. Hypertens. 2008, 30(7):486-496.
27. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Urieli-Shoval S., Galun E., Ben-Neriah Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431:461-466.
28. Thong T. Predicting imminent episodes of ventricular tachyarrhythmia-retrospective analysis of short R-R records from ICD. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2008, 2008:5664-5667.
29. Tracey K.J. The inflammatory reflex. Nature 2002, 420:853-859.
30. Tsutsumi T., Ide T., Yamato M., Kudou W., Andou M., Hirooka Y., Utsumi H., Tsutsui H., Sunagawa K. Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction. Cardiovasc. Res. 2008, 77(4):713-721.
31. Van Cutsem E., Peeters M., Verslype C., Filez L., Haustermans K., Janssens J. The medical treatment of colorectal cancer: actual status and new developments. Hepatogastroenterology 1999, 46(26):709-716.
32. Vlcek M., Radikova Z., Penesova A., Kvetnansky R., Imrich R. Heart rate variability and catecholamines during hypoglycemia and orthostasis. Auton. Neurosci. 2008, 143(1-2):53-57.
33. Voronov E., Shouval D.S., Krelin Y., Benharroch D., Iwakura Y., Dinarello C.A., Apte R.N. IL-1 is required for tumour invasiveness and angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:2645-2650.